Cancer Nanotheranostics: Volume 2

ISBN-13: 9783030762629 / Angielski / Twarda / 2021 / 520 str.

Muthupandian Saravanan; Hamed Barabadi

Spis treści

Preface

Chapter 1: Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Cancer

Dr. Rekha Pachaiappan, India

Chapter 2: Multifunctional Nanoparticles for Targeting Cancer Nanotheranostics

Dr. Ravichandran Manisekaran, Mexico

Chapter 3: Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives

Dr. Sanjeeb Sahoo, India

Chapter 4: Cancer-Targeted Nanotheranostics: Recent Advances and Future Perspectives

Dr. Maria Gazouli, Greece

Chapter 5: Nanotheranostics: A Future Remedy of Neurological Disorders

Dr. Saba Sohail, Pakistan

Chapter 6: Cancer Nano-Immunotherapy: Recent Advances and New Opportunites

Dr. Kamaraj Sathish-Kumar, Mexico

Chapter 7: Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics

Dr. Praveen T. Krishnamurthy, India

Chapter 8: Nanoparticle for Photoresponsive Minimal-Invasive Cancer Therapy

Dr. Shazid Md. Sharker, Bangladesh

Chapter 9: Biologically Synthesized Plant-Derived Nanomedicines and their In-Vitro In-Vivo Toxicity Studies in Various Cancer Therapeutics: Regulatory Perspectives

Dr. B. Balamuralikrishnan, Korea

Chapter 10: Nanoerythrosome: Biohybrid Microswimmers for Cancer Theranostics Cargo Delivery

Dr. Subbaraju Sree Gayathri, India

Chapter 11: Role of Artificial Intelligence in Cancer Nanotheranostics

Dr. Chockaiyan Usha, India

Chapter 12: Limitations of Current Cancer Nanotheranositcs

Dr. Sujata Sawarkar, India

Chapter 13; Safety of nanobiomaterials for Cancer Nanotheranostics

Dr. Sujata Sawarkar, India

Index

O autorze

Muthupandian Saravanan Graduated in Microbiology from Madurai Kamaraj University, India and Doctorate with Specialization in Medical Microbiology and Nanomedicine from Sathyabama University, India. Thereafter, He did a Post-Doctoral Research fellowship focusing his research on Nano-biomaterials & their Biomedical Applications (2011-2012). Prior to postdoc, he worked as an Assistant Professor (SG), SRM University, and Department of Biotechnology for six Years, from 2005 -2011. Presently, Dr. Saravanan working as a Professor, Department of Pharmacology Saveetha Dental college, SIMATS, Chennai, India and worked as Associate Professor, Department of Medical Microbiology and Immunology, Division of Bio-medical Sciences, School of Medicine, College of Health Science, Mekelle University, Ethiopia (2012-2021). His Research Specialization: Development of Novel biomaterials Emerging and Re-emerging Infectious disease and Cancer. He has published more than 150 research paper in Peer-reviewed Journal including high impact Journal with more than 8000 citations and h-index of 42 and i10 index of 85 and also three edited books.  He has participated more than 75 National and International conferences, Reviewers of more than 100 international peer-reviewed journals and Guest editor/ Editors for various reputed PubMed and Scopus indexed journals. He has received many fellowships and awards notably, IET- Nanobiotechnology premium Awards two times continuously in the year 2019 and 2020, DST-SERC Young Scientist fellowship in 2011, International Fellowship “Advanced Course on Diagnostics” Sponsored by LSH&TM & Fondation Mérieux, in France 2013, International Fellowship “Pertussis: biology, epidemiology and prevention” meeting Sponsored by Fondation Mérieux & WHO in France 2014, International Union of Microbiological Societies (IUMS) travel grant in 2015 to Canada, International Fellowship "Advanced Course on Antibiotics” (AdCAb) Sponsored by Institute of Pasteur and Fondation Mérieux France, 2016. His area of research includes Medical Microbiology, Antimicrobial Resistance, Nanomedicine, Nanomaterials to combat AMR and Cancer.

Hamed Barabadi (PharmD, PhD) works as an Assistant Professor at the Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. He obtained his PhD at Shahid Beheshti University of Medical Sciences, Tehran, Iran, in 2019. He graduated as a Doctor of Pharmacy (PharmD) from Mazandaran University of Medical Sciences, Sari, Iran, in 2014. Prior to starting his PhD, he served as a pharmaceutical expert at the Food and Drug Administration at the Department of Inspection and Supervision in Golestan Province, Iran, for two years. He owns to his credit a number of research papers and book chapters. He has received many awards such as IET- Nanobiotechnology premium Awards two times continuously in the year 2019 and 2020. Dr. Barabadi has been featured among the World's Top 2% Scientists List, according to a Stanford University study 2020. He is Guest editor/Editor for various reputed indexed journals such as Current Nanomedicine, Nanoscience and Nanotechnology-Asia, Frontiers in Pharmacology, Biocell, etc. His research interests lie in the area of pharmaceutical nanobiotechnology, ranging from green synthesis, characterization and optimization of nanobiomaterials to their pharmaceutical potential evaluations such as anticancer, antimicrobial, antioxidant, etc. Moreover, he has collaborated actively with researchers in several other disciplines of pharmaceutical sciences, particularly the nanoformulation of drugs for drug delivery systems and nanomedicine.

Blurb

Cancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two volumes are explained in detail as follows.

In the first volume of Cancer Nanotheranostics, we discussed the role of different nanomaterials for cancer therapy including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies.

This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics.

Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research.